Swiss National Bank Arcturus Therapeutics Holdings Inc. Transaction History

Swiss National Bank

  • $150 Billion
  • Q3 2024

A detailed history of Swiss National Bank transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Swiss National Bank holds 47,700 shares of ARCT stock, worth $807,561. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,700
Previous 47,700 -0.0%
Holding current value
$807,561
Previous $1.16 Million 4.65%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$24.35 - $44.39 $12,175 - $22,195
500 Added 1.06%
47,700 $1.16 Million
Q4 2023

Feb 06, 2024
SELL
$17.71 - $32.97 $95,634 - $178,038
-5,400 Reduced 10.27%
47,200 $1.49 Million
Q3 2023

Nov 08, 2023
BUY
$25.44 - $37.35 $12,720 - $18,675
500 Added 0.96%
52,600 $1.34 Million
Q2 2023

Aug 09, 2023
BUY
$23.94 - $32.36 $16,758 - $22,652
700 Added 1.36%
52,100 $1.49 Million
Q1 2023

May 10, 2023
SELL
$14.72 - $23.97 $92,736 - $151,011
-6,300 Reduced 10.92%
51,400 $1.23 Million
Q4 2022

Feb 08, 2023
BUY
$14.14 - $23.06 $25,452 - $41,508
1,800 Added 3.22%
57,700 $978,000
Q2 2022

Aug 09, 2022
BUY
$12.26 - $31.17 $73,560 - $187,020
6,000 Added 12.02%
55,900 $880,000
Q1 2022

May 09, 2022
BUY
$17.64 - $39.57 $63,504 - $142,452
3,600 Added 7.78%
49,900 $1.35 Million
Q2 2021

Aug 06, 2021
BUY
$25.79 - $42.11 $38,685 - $63,165
1,500 Added 3.35%
46,300 $1.57 Million
Q1 2021

May 07, 2021
BUY
$38.75 - $86.92 $27,125 - $60,844
700 Added 1.59%
44,800 $1.85 Million
Q4 2020

Feb 05, 2021
BUY
$34.61 - $123.66 $27,688 - $98,928
800 Added 1.85%
44,100 $1.91 Million
Q3 2020

Nov 09, 2020
BUY
$37.49 - $63.19 $374,900 - $631,900
10,000 Added 30.03%
43,300 $1.86 Million
Q2 2020

Aug 05, 2020
BUY
$12.66 - $58.27 $421,578 - $1.94 Million
33,300 New
33,300 $1.56 Million

Others Institutions Holding ARCT

# of Institutions
179
Shares Held
25.6M
Call Options Held
195K
Put Options Held
133K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $450M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email